TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2023
Back to search
Official data from USPTO
BRISTOL MYERS SQUIBB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/12/2023
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
04/02/2020
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
08/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/15/2021
First use in commerce
07/15/2021
Drawing code
3
Owner type
03
Owner location
Princeton, NJ
Examiner
BECHHOFER, YOCHEVED
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of five PANTONE Purple C vertical lines of varying lengths arranged next to each other resembling fingers on a hand where the first line curves at the bottom towards the right, positioned to the left of the gray words "BRISTOL MYERS SQUIBB".
Holders and representatives
Holders
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of obesityincontinencecardiovascular diseasescentral nervous system diseases and disordersmetabolic disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasessolid organ transplant rejectionbeta thalassemia and myelodysplastic syndromesmyeloproliferative diseasesmyelofibrosisleukemialymphomamultiple myelomaautoinflammatory diseaseblood diseasetumorsmultiple sclerosisulcerative colitisarthritismusculoskeletal and skin diseases; Pharmaceutical preparations for human useantibioticsanti-fungalsanti-viralsimmunosuppressantspharmaceutical antibodiesimmunotherapies for the treatment of cancercytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapyincluding T Cell therapy; Pharmaceutical preparations for human usestem cells for medical or clinical use
Class 42
Pharmaceutical research and development services
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
40 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/18/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/17/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/31/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/27/2023
IUAF
USE AMENDMENT FILED
03/15/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2022
EX3G
SOU EXTENSION 3 GRANTED
09/20/2022
EXT3
SOU EXTENSION 3 FILED
09/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/25/2022
EX2G
SOU EXTENSION 2 GRANTED
03/23/2022
EXT2
SOU EXTENSION 2 FILED
03/23/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/23/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/23/2021
EX1G
SOU EXTENSION 1 GRANTED
09/21/2021
EXT1
SOU EXTENSION 1 FILED
09/21/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/21/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/26/2021
PUBO
PUBLISHED FOR OPPOSITION
01/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2020
GNRT
NON-FINAL ACTION E-MAILED
06/25/2020
CNRT
NON-FINAL ACTION WRITTEN
06/25/2020
DOCK
ASSIGNED TO EXAMINER
06/22/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2020
NWAP
NEW APPLICATION ENTERED
04/06/2020
Continuous trademark protection
Get notified about every new filing that threatens BRISTOL MYERS SQUIBB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.